zollcodes.de
Anmelden Kostenloses Konto anlegen

Nummer 3004 90 · Position 3004

Arzneiwaren, die aus gemischten oder ungemischten Erzeugnissen zu therapeutischen oder prophylaktischen Zwecken bestehen, dosiert „einschließlich solcher, die über die Haut verabreicht werden“ oder in Aufmachungen für den Einzelverkauf (ausg. Antibiotika, Hormone oder als Hormone gebrauchte Steroide, Alkaloide, Provitamine, Vitamine, ihre Derivate, aktive Substanzen gegen Malaria oder Sets für blinde klinische Studien enthaltend)

Den amtlichen Wortlaut ansehen

Amtlicher Wortlaut

Arzneiwaren, die aus gemischten oder ungemischten Erzeugnissen zu therapeutischen oder prophylaktischen Zwecken bestehen, dosiert „einschließlich solcher, die über die Haut verabreicht werden“ oder in Aufmachungen für den Einzelverkauf (ausg. Antibiotika, Hormone oder als Hormone gebrauchte Steroide, Alkaloide, Provitamine, Vitamine, ihre Derivate, aktive Substanzen gegen Malaria oder Sets für blinde klinische Studien enthaltend)

Wie wir zu dieser Nummer gekommen sind

  1. VI
  2. 30
  3. 3004
  4. 3004 90
Die Schritte anzeigen

8-stellige Warennummer wählen

Einfuhrzoll für die folgenden Zolltarifnummern: 0.0%

Nur eine Nummer darunter

3004 90 00

Arzneiwaren, die aus gemischten oder ungemischten Erzeugnissen zu therapeutischen oder prophylaktischen Zwecken bestehen, dosiert „einschließlich solcher, die über die Haut verabreicht werden“ oder in Aufmachungen für den Einzelverkauf (ausg. Antibiotika, Hormone oder als Hormone gebrauchte Steroide, Alkaloide, Provitamine, Vitamine, ihre Derivate, aktive Substanzen gegen Malaria oder Sets für blinde klinische Studien enthaltend)

Zollfrei

Diese Unterposition enthält nur eine 8-stellige Warennummer. Verwenden Sie daher diese Warennummer.

Nummern auf derselben Ebene vergleichen

Alle 12 Nummern auf dieser Ebene ansehen

Verkauf nach Norwegen, Großbritannien und in die USA

Was dort bei der Einfuhr anfällt.

Norwegen, Großbritannien und die USA haben unter dem 6-stelligen HS-Code eigene Tariflinien. Die Sätze unten sind das, was ihr Zoll auf Waren aus der EU erhebt. Gleichen Sie die Ware mit dem Wortlaut des jeweiligen Landes ab, bevor Sie sich auf einen Satz verlassen.

Norwegen

Zollfrei

  • Landeseigene Linien2 norwegische Linien

30.04.9002 Containing narcotic drugs or psychotropic substances

Norwegische Zolldaten: geprüft 13. September 2026.

Großbritannien

Zollfrei

  • Landeseigene Linien1 britische Linie

3004 90 00 00 Other

Für Nordirland gelten andere Regeln.

Britische Zolldaten: geprüft 13. September 2026.

USA

0.0% oder 15.0%

Hängt von einer Frage ab

  • Landeseigene Linien75 amerikanische Linien
  • Einfuhrdatum18. September 2026

3004.90.10.00 Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed

Der amerikanische Einführer gibt die Zollanmeldung ab.

Amerikanische Zolldaten geprüft 16. September 2026.

Die 2 norwegischen Zeilen ansehen

Verkauf nach Norwegen

Norwegen unterteilt die 6-stellige Kategorie auf eigene Weise. Daher werden hier Norwegens eigene Untergliederungen dieser Kategorie angezeigt, nicht die vorliegende EU-Zolltarifnummer. Gleichen Sie Ihr Produkt mit den jeweiligen Warenbeschreibungen ab; der vom norwegischen Zoll erhobene Zoll ist in jeder Zeile angegeben.

  • 30.04.9002

    Containing narcotic drugs or psychotropic substances

    Regulärer Zollsatz
    Zollfrei
  • 30.04.9008

    Other

    Regulärer Zollsatz
    Zollfrei

Norwegische Tarifdaten, Version 1.5/1.2, zuletzt geprüft 13. September 2026.

Enthält Daten des norwegischen Zolls (data.toll.no), lizenziert unter CC BY 4.0, für die Anzeige angepasst.

Die 1 britische Zeile ansehen

Verkauf nach Großbritannien

Was der britische Zoll erhebt, wenn solche Waren in Großbritannien ankommen.

  • 3004 90 00 00

    Other

    Regulärer Zollsatz
    Zollfrei

Diese Sätze gelten in Großbritannien. Für Waren, die nach Nordirland gelangen, können andere Regeln gelten.

Britische Zolltarifdaten, Version v4.0.1599, zuletzt geprüft 13. September 2026.

Enthält Informationen des öffentlichen Sektors, lizenziert unter der Open Government Licence v3.0.

Quelle: UK Department for Business and Trade (data.api.trade.gov.uk).

Die 75 amerikanischen Linien ansehen

Verkauf in die USA

Was der amerikanische Zoll erhebt, wenn solche Waren aus der EU ankommen. Der amerikanische Einführer gibt die Zollanmeldung ab und zahlt den Zoll.

  • 3004.90.10.00

    Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Containing antigens or hyaluronic acid or its sodium salt

    Allgemeiner Satz
    Free
    Aus der EU
    0.0% oder 15.0% Hängt von einer Frage ab Angewendete amerikanische Positionen: 9903.04.62, 9903.05.86 Section 232 pharmaceuticals, Proclamation 11020 of 2 April 2026 (91 FR 18183) clauses (3)(c), (4), (5) and (7), heading 9903.04.62 of subchapter III of chapter 99 with U.S. note 40(c) and (f): the rate for patented pharmaceuticals and associated ingredients shall be 15 percent for products of the European Union, the sum of the column 1 duty rate and the additional duty being that rate; generic pharmaceuticals are not subject to tariffs pursuant to section 232 at this time; effective 31 July 2026 for the companies listed in Annex III and 29 September 2026 for other companiesU.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
  • 3004.90.92.01

    Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, For veterinary use

    Allgemeiner Satz
    Free
    Aus der EU
    0.0% oder 15.0% Hängt von einer Frage ab Angewendete amerikanische Positionen: 9903.04.62, 9903.05.86 Section 232 pharmaceuticals, Proclamation 11020 of 2 April 2026 (91 FR 18183) clauses (3)(c), (4), (5) and (7), heading 9903.04.62 of subchapter III of chapter 99 with U.S. note 40(c) and (f): the rate for patented pharmaceuticals and associated ingredients shall be 15 percent for products of the European Union, the sum of the column 1 duty rate and the additional duty being that rate; generic pharmaceuticals are not subject to tariffs pursuant to section 232 at this time; effective 31 July 2026 for the companies listed in Annex III and 29 September 2026 for other companiesU.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
  • 3004.90.92.03

    Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Anti-infective medicaments, Antivirals, Containing acyclovir or its salts

    Allgemeiner Satz
    Free
    Aus der EU
    0.0% Geschätzt anhand veröffentlichter amerikanischer Maßnahmen Angewendete amerikanische Positionen: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
  • 3004.90.92.04

    Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Anti-infective medicaments, Antivirals, Containing oseltamivir or its salts

    Allgemeiner Satz
    Free
    Aus der EU
    0.0% Geschätzt anhand veröffentlichter amerikanischer Maßnahmen Angewendete amerikanische Positionen: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
  • 3004.90.92.05

    Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Anti-infective medicaments, Antivirals, Containing valganciclovir, peramivir or their salts

    Allgemeiner Satz
    Free
    Aus der EU
    0.0% Geschätzt anhand veröffentlichter amerikanischer Maßnahmen Angewendete amerikanische Positionen: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
  • 3004.90.92.06

    Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Anti-infective medicaments, Antivirals, Other

    Allgemeiner Satz
    Free
    Aus der EU
    0.0% oder 15.0% Hängt von einer Frage ab Angewendete amerikanische Positionen: 9903.04.62, 9903.05.86 Section 232 pharmaceuticals, Proclamation 11020 of 2 April 2026 (91 FR 18183) clauses (3)(c), (4), (5) and (7), heading 9903.04.62 of subchapter III of chapter 99 with U.S. note 40(c) and (f): the rate for patented pharmaceuticals and associated ingredients shall be 15 percent for products of the European Union, the sum of the column 1 duty rate and the additional duty being that rate; generic pharmaceuticals are not subject to tariffs pursuant to section 232 at this time; effective 31 July 2026 for the companies listed in Annex III and 29 September 2026 for other companiesU.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
  • 3004.90.92.07

    Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Anti-infective medicaments, Antifungals, Containing fluconazole or its salts

    Allgemeiner Satz
    Free
    Aus der EU
    0.0% Geschätzt anhand veröffentlichter amerikanischer Maßnahmen Angewendete amerikanische Positionen: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
  • 3004.90.92.08

    Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Anti-infective medicaments, Antifungals, Other

    Allgemeiner Satz
    Free
    Aus der EU
    0.0% oder 15.0% Hängt von einer Frage ab Angewendete amerikanische Positionen: 9903.04.62, 9903.05.86 Section 232 pharmaceuticals, Proclamation 11020 of 2 April 2026 (91 FR 18183) clauses (3)(c), (4), (5) and (7), heading 9903.04.62 of subchapter III of chapter 99 with U.S. note 40(c) and (f): the rate for patented pharmaceuticals and associated ingredients shall be 15 percent for products of the European Union, the sum of the column 1 duty rate and the additional duty being that rate; generic pharmaceuticals are not subject to tariffs pursuant to section 232 at this time; effective 31 July 2026 for the companies listed in Annex III and 29 September 2026 for other companiesU.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
Alle 75 Zeilen anzeigen
  • 3004.90.92.09

    Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Anti-infective medicaments, Antiprotozoals (excluding goods described in subheading note 2 to this chapter), Containing metronidazole or its salts

    Allgemeiner Satz
    Free
    Aus der EU
    0.0% Geschätzt anhand veröffentlichter amerikanischer Maßnahmen Angewendete amerikanische Positionen: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
  • 3004.90.92.10

    Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Anti-infective medicaments, Antiprotozoals (excluding goods described in subheading note 2 to this chapter), Other

    Allgemeiner Satz
    Free
    Aus der EU
    0.0% oder 15.0% Hängt von einer Frage ab Angewendete amerikanische Positionen: 9903.04.62, 9903.05.86 Section 232 pharmaceuticals, Proclamation 11020 of 2 April 2026 (91 FR 18183) clauses (3)(c), (4), (5) and (7), heading 9903.04.62 of subchapter III of chapter 99 with U.S. note 40(c) and (f): the rate for patented pharmaceuticals and associated ingredients shall be 15 percent for products of the European Union, the sum of the column 1 duty rate and the additional duty being that rate; generic pharmaceuticals are not subject to tariffs pursuant to section 232 at this time; effective 31 July 2026 for the companies listed in Annex III and 29 September 2026 for other companiesU.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
  • 3004.90.92.11

    Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Anti-infective medicaments, Sulfonamides, Containing trimethoprim and sulfamethoxazole or their salts

    Allgemeiner Satz
    Free
    Aus der EU
    0.0% oder 15.0% Hängt von einer Frage ab Angewendete amerikanische Positionen: 9903.04.62, 9903.05.86 Section 232 pharmaceuticals, Proclamation 11020 of 2 April 2026 (91 FR 18183) clauses (3)(c), (4), (5) and (7), heading 9903.04.62 of subchapter III of chapter 99 with U.S. note 40(c) and (f): the rate for patented pharmaceuticals and associated ingredients shall be 15 percent for products of the European Union, the sum of the column 1 duty rate and the additional duty being that rate; generic pharmaceuticals are not subject to tariffs pursuant to section 232 at this time; effective 31 July 2026 for the companies listed in Annex III and 29 September 2026 for other companiesU.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
  • 3004.90.92.12

    Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Anti-infective medicaments, Sulfonamides, Other

    Allgemeiner Satz
    Free
    Aus der EU
    0.0% Geschätzt anhand veröffentlichter amerikanischer Maßnahmen Angewendete amerikanische Positionen: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
  • 3004.90.92.13

    Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Anti-infective medicaments, Other, Containing levofloxacin or its salts

    Allgemeiner Satz
    Free
    Aus der EU
    0.0% Geschätzt anhand veröffentlichter amerikanischer Maßnahmen Angewendete amerikanische Positionen: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
  • 3004.90.92.14

    Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Anti-infective medicaments, Other, Containing linezolid or its salts

    Allgemeiner Satz
    Free
    Aus der EU
    0.0% Geschätzt anhand veröffentlichter amerikanischer Maßnahmen Angewendete amerikanische Positionen: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
  • 3004.90.92.15

    Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Anti-infective medicaments, Other

    Allgemeiner Satz
    Free
    Aus der EU
    0.0% oder 15.0% Hängt von einer Frage ab Angewendete amerikanische Positionen: 9903.04.62, 9903.05.86 Section 232 pharmaceuticals, Proclamation 11020 of 2 April 2026 (91 FR 18183) clauses (3)(c), (4), (5) and (7), heading 9903.04.62 of subchapter III of chapter 99 with U.S. note 40(c) and (f): the rate for patented pharmaceuticals and associated ingredients shall be 15 percent for products of the European Union, the sum of the column 1 duty rate and the additional duty being that rate; generic pharmaceuticals are not subject to tariffs pursuant to section 232 at this time; effective 31 July 2026 for the companies listed in Annex III and 29 September 2026 for other companiesU.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
  • 3004.90.92.16

    Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Antineoplastic and immunosuppressive medicaments, Containing hydroxyurea or cyclophosphamide or their salts

    Allgemeiner Satz
    Free
    Aus der EU
    0.0% oder 15.0% Hängt von einer Frage ab Angewendete amerikanische Positionen: 9903.04.62, 9903.05.86 Section 232 pharmaceuticals, Proclamation 11020 of 2 April 2026 (91 FR 18183) clauses (3)(c), (4), (5) and (7), heading 9903.04.62 of subchapter III of chapter 99 with U.S. note 40(c) and (f): the rate for patented pharmaceuticals and associated ingredients shall be 15 percent for products of the European Union, the sum of the column 1 duty rate and the additional duty being that rate; generic pharmaceuticals are not subject to tariffs pursuant to section 232 at this time; effective 31 July 2026 for the companies listed in Annex III and 29 September 2026 for other companiesU.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
  • 3004.90.92.17

    Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Antineoplastic and immunosuppressive medicaments, Containing tacrolimus or mycophenolate mofetil or its salts

    Allgemeiner Satz
    Free
    Aus der EU
    0.0% Geschätzt anhand veröffentlichter amerikanischer Maßnahmen Angewendete amerikanische Positionen: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
  • 3004.90.92.18

    Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Antineoplastic and immunosuppressive medicaments, Other

    Allgemeiner Satz
    Free
    Aus der EU
    0.0% Geschätzt anhand veröffentlichter amerikanischer Maßnahmen Angewendete amerikanische Positionen: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
  • 3004.90.92.19

    Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Cardiovascular medicaments, Containing metoprolol or its salts

    Allgemeiner Satz
    Free
    Aus der EU
    0.0% Geschätzt anhand veröffentlichter amerikanischer Maßnahmen Angewendete amerikanische Positionen: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
  • 3004.90.92.20

    Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Cardiovascular medicaments, Containing amiodarone or its salts

    Allgemeiner Satz
    Free
    Aus der EU
    0.0% Geschätzt anhand veröffentlichter amerikanischer Maßnahmen Angewendete amerikanische Positionen: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
  • 3004.90.92.21

    Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Cardiovascular medicaments, Containing diltiazem or its salts

    Allgemeiner Satz
    Free
    Aus der EU
    0.0% Geschätzt anhand veröffentlichter amerikanischer Maßnahmen Angewendete amerikanische Positionen: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
  • 3004.90.92.22

    Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Cardiovascular medicaments, Containing hydralazine or its salts

    Allgemeiner Satz
    Free
    Aus der EU
    0.0% Geschätzt anhand veröffentlichter amerikanischer Maßnahmen Angewendete amerikanische Positionen: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
  • 3004.90.92.23

    Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Cardiovascular medicaments, Containing enoxaparin or its salts

    Allgemeiner Satz
    Free
    Aus der EU
    0.0% Geschätzt anhand veröffentlichter amerikanischer Maßnahmen Angewendete amerikanische Positionen: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
  • 3004.90.92.24

    Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Cardiovascular medicaments, Containing labetalol or its salts

    Allgemeiner Satz
    Free
    Aus der EU
    0.0% Geschätzt anhand veröffentlichter amerikanischer Maßnahmen Angewendete amerikanische Positionen: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
  • 3004.90.92.25

    Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Cardiovascular medicaments, Containing argatroban, adenosine, amlodipine, esmolol, dobutamine, phenoxybenzamine or their salts

    Allgemeiner Satz
    Free
    Aus der EU
    0.0% oder 15.0% Hängt von einer Frage ab Angewendete amerikanische Positionen: 9903.04.62, 9903.05.86 Section 232 pharmaceuticals, Proclamation 11020 of 2 April 2026 (91 FR 18183) clauses (3)(c), (4), (5) and (7), heading 9903.04.62 of subchapter III of chapter 99 with U.S. note 40(c) and (f): the rate for patented pharmaceuticals and associated ingredients shall be 15 percent for products of the European Union, the sum of the column 1 duty rate and the additional duty being that rate; generic pharmaceuticals are not subject to tariffs pursuant to section 232 at this time; effective 31 July 2026 for the companies listed in Annex III and 29 September 2026 for other companiesU.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
  • 3004.90.92.26

    Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Cardiovascular medicaments, Other

    Allgemeiner Satz
    Free
    Aus der EU
    0.0% Geschätzt anhand veröffentlichter amerikanischer Maßnahmen Angewendete amerikanische Positionen: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
  • 3004.90.92.27

    Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Medicaments primarily affecting the central nervous system, Analgesics, antipyretics and nonhormonal anti-inflammatory agents, Tolmetin

    Allgemeiner Satz
    Free
    Aus der EU
    0.0% Geschätzt anhand veröffentlichter amerikanischer Maßnahmen Angewendete amerikanische Positionen: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
  • 3004.90.92.28

    Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Medicaments primarily affecting the central nervous system, Analgesics, antipyretics and nonhormonal anti-inflammatory agents, Tolmetin sodium dihydrate

    Allgemeiner Satz
    Free
    Aus der EU
    0.0% Geschätzt anhand veröffentlichter amerikanischer Maßnahmen Angewendete amerikanische Positionen: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
  • 3004.90.92.29

    Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Medicaments primarily affecting the central nervous system, Analgesics, antipyretics and nonhormonal anti-inflammatory agents, Tolmetin sodium (anhydrous)

    Allgemeiner Satz
    Free
    Aus der EU
    0.0% Geschätzt anhand veröffentlichter amerikanischer Maßnahmen Angewendete amerikanische Positionen: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
  • 3004.90.92.30

    Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Medicaments primarily affecting the central nervous system, Analgesics, antipyretics and nonhormonal anti-inflammatory agents, Containing ibuprofen or its salts, For oral suspension

    Allgemeiner Satz
    Free
    Aus der EU
    0.0% Geschätzt anhand veröffentlichter amerikanischer Maßnahmen Angewendete amerikanische Positionen: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
  • 3004.90.92.31

    Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Medicaments primarily affecting the central nervous system, Analgesics, antipyretics and nonhormonal anti-inflammatory agents, Containing ibuprofen or its salts, Other

    Allgemeiner Satz
    Free
    Aus der EU
    0.0% Geschätzt anhand veröffentlichter amerikanischer Maßnahmen Angewendete amerikanische Positionen: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
  • 3004.90.92.32

    Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Medicaments primarily affecting the central nervous system, Analgesics, antipyretics and nonhormonal anti-inflammatory agents, Containing acetaminophen or its salts, For oral suspension

    Allgemeiner Satz
    Free
    Aus der EU
    0.0% Geschätzt anhand veröffentlichter amerikanischer Maßnahmen Angewendete amerikanische Positionen: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
  • 3004.90.92.33

    Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Medicaments primarily affecting the central nervous system, Analgesics, antipyretics and nonhormonal anti-inflammatory agents, Containing acetaminophen or its salts, Other

    Allgemeiner Satz
    Free
    Aus der EU
    0.0% Geschätzt anhand veröffentlichter amerikanischer Maßnahmen Angewendete amerikanische Positionen: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
  • 3004.90.92.34

    Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Medicaments primarily affecting the central nervous system, Analgesics, antipyretics and nonhormonal anti-inflammatory agents, Containing O-Acetylsalicylic acid (Aspirin)

    Allgemeiner Satz
    Free
    Aus der EU
    0.0% Geschätzt anhand veröffentlichter amerikanischer Maßnahmen Angewendete amerikanische Positionen: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
  • 3004.90.92.35

    Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Medicaments primarily affecting the central nervous system, Analgesics, antipyretics and nonhormonal anti-inflammatory agents, Containing tramadol

    Allgemeiner Satz
    Free
    Aus der EU
    0.0% Geschätzt anhand veröffentlichter amerikanischer Maßnahmen Angewendete amerikanische Positionen: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
  • 3004.90.92.36

    Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Medicaments primarily affecting the central nervous system, Analgesics, antipyretics and nonhormonal anti-inflammatory agents, Other

    Allgemeiner Satz
    Free
    Aus der EU
    0.0% oder 15.0% Hängt von einer Frage ab Angewendete amerikanische Positionen: 9903.04.62, 9903.05.86 Section 232 pharmaceuticals, Proclamation 11020 of 2 April 2026 (91 FR 18183) clauses (3)(c), (4), (5) and (7), heading 9903.04.62 of subchapter III of chapter 99 with U.S. note 40(c) and (f): the rate for patented pharmaceuticals and associated ingredients shall be 15 percent for products of the European Union, the sum of the column 1 duty rate and the additional duty being that rate; generic pharmaceuticals are not subject to tariffs pursuant to section 232 at this time; effective 31 July 2026 for the companies listed in Annex III and 29 September 2026 for other companiesU.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
  • 3004.90.92.37

    Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Medicaments primarily affecting the central nervous system, Anticonvulsants, hypnotics and sedatives, Containing dexmedetomidine, etomidate, midazolam, propofol or their salts

    Allgemeiner Satz
    Free
    Aus der EU
    0.0% Geschätzt anhand veröffentlichter amerikanischer Maßnahmen Angewendete amerikanische Positionen: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
  • 3004.90.92.38

    Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Medicaments primarily affecting the central nervous system, Anticonvulsants, hypnotics and sedatives, Containing midazolam or its salts

    Allgemeiner Satz
    Free
    Aus der EU
    0.0% Geschätzt anhand veröffentlichter amerikanischer Maßnahmen Angewendete amerikanische Positionen: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
  • 3004.90.92.39

    Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Medicaments primarily affecting the central nervous system, Anticonvulsants, hypnotics and sedatives, Containing phenytoin or its salts

    Allgemeiner Satz
    Free
    Aus der EU
    0.0% Geschätzt anhand veröffentlichter amerikanischer Maßnahmen Angewendete amerikanische Positionen: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
  • 3004.90.92.40

    Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Medicaments primarily affecting the central nervous system, Anticonvulsants, hypnotics and sedatives, Containing propofol or its salts

    Allgemeiner Satz
    Free
    Aus der EU
    0.0% Geschätzt anhand veröffentlichter amerikanischer Maßnahmen Angewendete amerikanische Positionen: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
  • 3004.90.92.41

    Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Medicaments primarily affecting the central nervous system, Anticonvulsants, hypnotics and sedatives, Containing levetiracetam, phenytoin or their salts

    Allgemeiner Satz
    Free
    Aus der EU
    0.0% Geschätzt anhand veröffentlichter amerikanischer Maßnahmen Angewendete amerikanische Positionen: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
  • 3004.90.92.42

    Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Medicaments primarily affecting the central nervous system, Anticonvulsants, hypnotics and sedatives, Containing etomidate or its salts

    Allgemeiner Satz
    Free
    Aus der EU
    0.0% Geschätzt anhand veröffentlichter amerikanischer Maßnahmen Angewendete amerikanische Positionen: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
  • 3004.90.92.43

    Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Medicaments primarily affecting the central nervous system, Anticonvulsants, hypnotics and sedatives, Other

    Allgemeiner Satz
    Free
    Aus der EU
    0.0% oder 15.0% Hängt von einer Frage ab Angewendete amerikanische Positionen: 9903.04.62, 9903.05.86 Section 232 pharmaceuticals, Proclamation 11020 of 2 April 2026 (91 FR 18183) clauses (3)(c), (4), (5) and (7), heading 9903.04.62 of subchapter III of chapter 99 with U.S. note 40(c) and (f): the rate for patented pharmaceuticals and associated ingredients shall be 15 percent for products of the European Union, the sum of the column 1 duty rate and the additional duty being that rate; generic pharmaceuticals are not subject to tariffs pursuant to section 232 at this time; effective 31 July 2026 for the companies listed in Annex III and 29 September 2026 for other companiesU.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
  • 3004.90.92.44

    Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Medicaments primarily affecting the central nervous system, Antidepressants, tranquilizers, and other psychotherapeutic agents, Containing lorazepam or its salts

    Allgemeiner Satz
    Free
    Aus der EU
    0.0% Geschätzt anhand veröffentlichter amerikanischer Maßnahmen Angewendete amerikanische Positionen: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
  • 3004.90.92.45

    Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Medicaments primarily affecting the central nervous system, Antidepressants, tranquilizers, and other psychotherapeutic agents, Containing olanzapine or its salts

    Allgemeiner Satz
    Free
    Aus der EU
    0.0% Geschätzt anhand veröffentlichter amerikanischer Maßnahmen Angewendete amerikanische Positionen: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
  • 3004.90.92.46

    Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Medicaments primarily affecting the central nervous system, Antidepressants, tranquilizers, and other psychotherapeutic agents, Other

    Allgemeiner Satz
    Free
    Aus der EU
    0.0% oder 15.0% Hängt von einer Frage ab Angewendete amerikanische Positionen: 9903.04.62, 9903.05.86 Section 232 pharmaceuticals, Proclamation 11020 of 2 April 2026 (91 FR 18183) clauses (3)(c), (4), (5) and (7), heading 9903.04.62 of subchapter III of chapter 99 with U.S. note 40(c) and (f): the rate for patented pharmaceuticals and associated ingredients shall be 15 percent for products of the European Union, the sum of the column 1 duty rate and the additional duty being that rate; generic pharmaceuticals are not subject to tariffs pursuant to section 232 at this time; effective 31 July 2026 for the companies listed in Annex III and 29 September 2026 for other companiesU.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
  • 3004.90.92.47

    Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Medicaments primarily affecting the central nervous system, Other, Containing rocuronium or its salts

    Allgemeiner Satz
    Free
    Aus der EU
    0.0% Geschätzt anhand veröffentlichter amerikanischer Maßnahmen Angewendete amerikanische Positionen: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
  • 3004.90.92.48

    Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Medicaments primarily affecting the central nervous system, Other, Containing succinylcholine or its salts

    Allgemeiner Satz
    Free
    Aus der EU
    0.0% Geschätzt anhand veröffentlichter amerikanischer Maßnahmen Angewendete amerikanische Positionen: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
  • 3004.90.92.49

    Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Medicaments primarily affecting the central nervous system, Other

    Allgemeiner Satz
    Free
    Aus der EU
    0.0% oder 15.0% Hängt von einer Frage ab Angewendete amerikanische Positionen: 9903.04.62, 9903.05.86 Section 232 pharmaceuticals, Proclamation 11020 of 2 April 2026 (91 FR 18183) clauses (3)(c), (4), (5) and (7), heading 9903.04.62 of subchapter III of chapter 99 with U.S. note 40(c) and (f): the rate for patented pharmaceuticals and associated ingredients shall be 15 percent for products of the European Union, the sum of the column 1 duty rate and the additional duty being that rate; generic pharmaceuticals are not subject to tariffs pursuant to section 232 at this time; effective 31 July 2026 for the companies listed in Annex III and 29 September 2026 for other companiesU.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
  • 3004.90.92.50

    Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Dermatological agents and local anesthetics, Containing lidocaine or its salts

    Allgemeiner Satz
    Free
    Aus der EU
    0.0% Geschätzt anhand veröffentlichter amerikanischer Maßnahmen Angewendete amerikanische Positionen: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
  • 3004.90.92.51

    Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Dermatological agents and local anesthetics, Other

    Allgemeiner Satz
    Free
    Aus der EU
    0.0% oder 15.0% Hängt von einer Frage ab Angewendete amerikanische Positionen: 9903.04.62, 9903.05.86 Section 232 pharmaceuticals, Proclamation 11020 of 2 April 2026 (91 FR 18183) clauses (3)(c), (4), (5) and (7), heading 9903.04.62 of subchapter III of chapter 99 with U.S. note 40(c) and (f): the rate for patented pharmaceuticals and associated ingredients shall be 15 percent for products of the European Union, the sum of the column 1 duty rate and the additional duty being that rate; generic pharmaceuticals are not subject to tariffs pursuant to section 232 at this time; effective 31 July 2026 for the companies listed in Annex III and 29 September 2026 for other companiesU.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
  • 3004.90.92.52

    Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Medicaments primarily affecting the digestive system, Laxatives

    Allgemeiner Satz
    Free
    Aus der EU
    0.0% oder 15.0% Hängt von einer Frage ab Angewendete amerikanische Positionen: 9903.04.62, 9903.05.86 Section 232 pharmaceuticals, Proclamation 11020 of 2 April 2026 (91 FR 18183) clauses (3)(c), (4), (5) and (7), heading 9903.04.62 of subchapter III of chapter 99 with U.S. note 40(c) and (f): the rate for patented pharmaceuticals and associated ingredients shall be 15 percent for products of the European Union, the sum of the column 1 duty rate and the additional duty being that rate; generic pharmaceuticals are not subject to tariffs pursuant to section 232 at this time; effective 31 July 2026 for the companies listed in Annex III and 29 September 2026 for other companiesU.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
  • 3004.90.92.53

    Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Medicaments primarily affecting the digestive system, Antacids

    Allgemeiner Satz
    Free
    Aus der EU
    0.0% oder 15.0% Hängt von einer Frage ab Angewendete amerikanische Positionen: 9903.04.62, 9903.05.86 Section 232 pharmaceuticals, Proclamation 11020 of 2 April 2026 (91 FR 18183) clauses (3)(c), (4), (5) and (7), heading 9903.04.62 of subchapter III of chapter 99 with U.S. note 40(c) and (f): the rate for patented pharmaceuticals and associated ingredients shall be 15 percent for products of the European Union, the sum of the column 1 duty rate and the additional duty being that rate; generic pharmaceuticals are not subject to tariffs pursuant to section 232 at this time; effective 31 July 2026 for the companies listed in Annex III and 29 September 2026 for other companiesU.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
  • 3004.90.92.54

    Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Medicaments primarily affecting the digestive system, Containing famotidine or its salts

    Allgemeiner Satz
    Free
    Aus der EU
    0.0% Geschätzt anhand veröffentlichter amerikanischer Maßnahmen Angewendete amerikanische Positionen: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
  • 3004.90.92.55

    Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Medicaments primarily affecting the digestive system, Containing pantoprazole or its salts

    Allgemeiner Satz
    Free
    Aus der EU
    0.0% Geschätzt anhand veröffentlichter amerikanischer Maßnahmen Angewendete amerikanische Positionen: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
  • 3004.90.92.56

    Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Medicaments primarily affecting the digestive system, Containing ondansetron or its salts

    Allgemeiner Satz
    Free
    Aus der EU
    0.0% Geschätzt anhand veröffentlichter amerikanischer Maßnahmen Angewendete amerikanische Positionen: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
  • 3004.90.92.57

    Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Medicaments primarily affecting the digestive system, Containing glycopyrrolate or its salts

    Allgemeiner Satz
    Free
    Aus der EU
    0.0% Geschätzt anhand veröffentlichter amerikanischer Maßnahmen Angewendete amerikanische Positionen: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
  • 3004.90.92.58

    Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Medicaments primarily affecting the digestive system, Containing loperamide or its salts

    Allgemeiner Satz
    Free
    Aus der EU
    0.0% Geschätzt anhand veröffentlichter amerikanischer Maßnahmen Angewendete amerikanische Positionen: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
  • 3004.90.92.60

    Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Medicaments primarily affecting the digestive system, Other

    Allgemeiner Satz
    Free
    Aus der EU
    0.0% oder 15.0% Hängt von einer Frage ab Angewendete amerikanische Positionen: 9903.04.62, 9903.05.86 Section 232 pharmaceuticals, Proclamation 11020 of 2 April 2026 (91 FR 18183) clauses (3)(c), (4), (5) and (7), heading 9903.04.62 of subchapter III of chapter 99 with U.S. note 40(c) and (f): the rate for patented pharmaceuticals and associated ingredients shall be 15 percent for products of the European Union, the sum of the column 1 duty rate and the additional duty being that rate; generic pharmaceuticals are not subject to tariffs pursuant to section 232 at this time; effective 31 July 2026 for the companies listed in Annex III and 29 September 2026 for other companiesU.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
  • 3004.90.92.61

    Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Preparations primarily affecting the electrolytic, caloric or water balance, Diuretics, Containing furosemide and its salts

    Allgemeiner Satz
    Free
    Aus der EU
    0.0% Geschätzt anhand veröffentlichter amerikanischer Maßnahmen Angewendete amerikanische Positionen: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
  • 3004.90.92.62

    Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Preparations primarily affecting the electrolytic, caloric or water balance, Diuretics, Containing hydrochlorothiazide or its salts

    Allgemeiner Satz
    Free
    Aus der EU
    0.0% Geschätzt anhand veröffentlichter amerikanischer Maßnahmen Angewendete amerikanische Positionen: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
  • 3004.90.92.63

    Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Preparations primarily affecting the electrolytic, caloric or water balance, Diuretics, Other

    Allgemeiner Satz
    Free
    Aus der EU
    0.0% oder 15.0% Hängt von einer Frage ab Angewendete amerikanische Positionen: 9903.04.62, 9903.05.86 Section 232 pharmaceuticals, Proclamation 11020 of 2 April 2026 (91 FR 18183) clauses (3)(c), (4), (5) and (7), heading 9903.04.62 of subchapter III of chapter 99 with U.S. note 40(c) and (f): the rate for patented pharmaceuticals and associated ingredients shall be 15 percent for products of the European Union, the sum of the column 1 duty rate and the additional duty being that rate; generic pharmaceuticals are not subject to tariffs pursuant to section 232 at this time; effective 31 July 2026 for the companies listed in Annex III and 29 September 2026 for other companiesU.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
  • 3004.90.92.64

    Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Preparations primarily affecting the electrolytic, caloric or water balance, Other, Containing calcium gluconate

    Allgemeiner Satz
    Free
    Aus der EU
    0.0% Geschätzt anhand veröffentlichter amerikanischer Maßnahmen Angewendete amerikanische Positionen: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
  • 3004.90.92.65

    Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Preparations primarily affecting the electrolytic, caloric or water balance, Other, Containing potassium chloride

    Allgemeiner Satz
    Free
    Aus der EU
    0.0% Geschätzt anhand veröffentlichter amerikanischer Maßnahmen Angewendete amerikanische Positionen: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
  • 3004.90.92.66

    Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Preparations primarily affecting the electrolytic, caloric or water balance, Other, Containing sodium bicarbonate, in injection form

    Allgemeiner Satz
    Free
    Aus der EU
    0.0% Geschätzt anhand veröffentlichter amerikanischer Maßnahmen Angewendete amerikanische Positionen: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
  • 3004.90.92.67

    Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Preparations primarily affecting the electrolytic, caloric or water balance, Other

    Allgemeiner Satz
    Free
    Aus der EU
    0.0% oder 15.0% Hängt von einer Frage ab Angewendete amerikanische Positionen: 9903.04.62, 9903.05.86 Section 232 pharmaceuticals, Proclamation 11020 of 2 April 2026 (91 FR 18183) clauses (3)(c), (4), (5) and (7), heading 9903.04.62 of subchapter III of chapter 99 with U.S. note 40(c) and (f): the rate for patented pharmaceuticals and associated ingredients shall be 15 percent for products of the European Union, the sum of the column 1 duty rate and the additional duty being that rate; generic pharmaceuticals are not subject to tariffs pursuant to section 232 at this time; effective 31 July 2026 for the companies listed in Annex III and 29 September 2026 for other companiesU.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
  • 3004.90.92.68

    Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Medicaments primarily affecting the eyes, ears, or respiratory system, Cough and cold preparations

    Allgemeiner Satz
    Free
    Aus der EU
    0.0% oder 15.0% Hängt von einer Frage ab Angewendete amerikanische Positionen: 9903.04.62, 9903.05.86 Section 232 pharmaceuticals, Proclamation 11020 of 2 April 2026 (91 FR 18183) clauses (3)(c), (4), (5) and (7), heading 9903.04.62 of subchapter III of chapter 99 with U.S. note 40(c) and (f): the rate for patented pharmaceuticals and associated ingredients shall be 15 percent for products of the European Union, the sum of the column 1 duty rate and the additional duty being that rate; generic pharmaceuticals are not subject to tariffs pursuant to section 232 at this time; effective 31 July 2026 for the companies listed in Annex III and 29 September 2026 for other companiesU.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
  • 3004.90.92.69

    Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Medicaments primarily affecting the eyes, ears, or respiratory system, Other, Antihistamines, Containing diphenhydramine or its salts

    Allgemeiner Satz
    Free
    Aus der EU
    0.0% Geschätzt anhand veröffentlichter amerikanischer Maßnahmen Angewendete amerikanische Positionen: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
  • 3004.90.92.70

    Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Medicaments primarily affecting the eyes, ears, or respiratory system, Other, Antihistamines, Other

    Allgemeiner Satz
    Free
    Aus der EU
    0.0% oder 15.0% Hängt von einer Frage ab Angewendete amerikanische Positionen: 9903.04.62, 9903.05.86 Section 232 pharmaceuticals, Proclamation 11020 of 2 April 2026 (91 FR 18183) clauses (3)(c), (4), (5) and (7), heading 9903.04.62 of subchapter III of chapter 99 with U.S. note 40(c) and (f): the rate for patented pharmaceuticals and associated ingredients shall be 15 percent for products of the European Union, the sum of the column 1 duty rate and the additional duty being that rate; generic pharmaceuticals are not subject to tariffs pursuant to section 232 at this time; effective 31 July 2026 for the companies listed in Annex III and 29 September 2026 for other companiesU.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
  • 3004.90.92.71

    Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Medicaments primarily affecting the eyes, ears, or respiratory system, Other, Containing albuterol sulfate

    Allgemeiner Satz
    Free
    Aus der EU
    0.0% oder 15.0% Hängt von einer Frage ab Angewendete amerikanische Positionen: 9903.04.62, 9903.05.86 Section 232 pharmaceuticals, Proclamation 11020 of 2 April 2026 (91 FR 18183) clauses (3)(c), (4), (5) and (7), heading 9903.04.62 of subchapter III of chapter 99 with U.S. note 40(c) and (f): the rate for patented pharmaceuticals and associated ingredients shall be 15 percent for products of the European Union, the sum of the column 1 duty rate and the additional duty being that rate; generic pharmaceuticals are not subject to tariffs pursuant to section 232 at this time; effective 31 July 2026 for the companies listed in Annex III and 29 September 2026 for other companiesU.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
  • 3004.90.92.72

    Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Medicaments primarily affecting the eyes, ears, or respiratory system, Other, Containing timolol maleate

    Allgemeiner Satz
    Free
    Aus der EU
    0.0% Geschätzt anhand veröffentlichter amerikanischer Maßnahmen Angewendete amerikanische Positionen: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
  • 3004.90.92.73

    Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Medicaments primarily affecting the eyes, ears, or respiratory system, Other

    Allgemeiner Satz
    Free
    Aus der EU
    0.0% oder 15.0% Hängt von einer Frage ab Angewendete amerikanische Positionen: 9903.04.62, 9903.05.86 Section 232 pharmaceuticals, Proclamation 11020 of 2 April 2026 (91 FR 18183) clauses (3)(c), (4), (5) and (7), heading 9903.04.62 of subchapter III of chapter 99 with U.S. note 40(c) and (f): the rate for patented pharmaceuticals and associated ingredients shall be 15 percent for products of the European Union, the sum of the column 1 duty rate and the additional duty being that rate; generic pharmaceuticals are not subject to tariffs pursuant to section 232 at this time; effective 31 July 2026 for the companies listed in Annex III and 29 September 2026 for other companiesU.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
  • 3004.90.92.74

    Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Containing heparin sodium or its salts

    Allgemeiner Satz
    Free
    Aus der EU
    0.0% Geschätzt anhand veröffentlichter amerikanischer Maßnahmen Angewendete amerikanische Positionen: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
  • 3004.90.92.75

    Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other, Containing zoledronic acid or its salts

    Allgemeiner Satz
    Free
    Aus der EU
    0.0% Geschätzt anhand veröffentlichter amerikanischer Maßnahmen Angewendete amerikanische Positionen: 9903.05.86 U.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions
  • 3004.90.92.76

    Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale, Other

    Allgemeiner Satz
    Free
    Aus der EU
    0.0% oder 15.0% Hängt von einer Frage ab Angewendete amerikanische Positionen: 9903.04.62, 9903.05.86 Section 232 pharmaceuticals, Proclamation 11020 of 2 April 2026 (91 FR 18183) clauses (3)(c), (4), (5) and (7), heading 9903.04.62 of subchapter III of chapter 99 with U.S. note 40(c) and (f): the rate for patented pharmaceuticals and associated ingredients shall be 15 percent for products of the European Union, the sum of the column 1 duty rate and the additional duty being that rate; generic pharmaceuticals are not subject to tariffs pursuant to section 232 at this time; effective 31 July 2026 for the companies listed in Annex III and 29 September 2026 for other companiesU.S. note 52(b) to subchapter III of chapter 99, 91 FR 47318: as provided in heading 9903.05.86, the duties imposed by headings 9903.05.20 through 9903.05.84 shall not apply to articles classifiable in the listed provisions

Berechnet für eine Einfuhr am 18. September 2026.

Amerikanischer Zolltarif, Version 2026HTSRev19, zuletzt geprüft 16. September 2026.

Letzte von uns erfasste Änderung: Revision 19 (2026), 16. September 2026.

Antidumpingzölle, Ausgleichszölle, amerikanische Einfuhrabgaben und Zollgebühren sind nicht enthalten.

Die Beschreibungen oben sind die amerikanischen Zolltariftexte, die die USA nur auf Englisch veröffentlichen.

Quelle: der amerikanische Zolltarif der US International Trade Commission (hts.usitc.gov), public domain, sowie die im Federal Register veröffentlichten Maßnahmen.

Dies ist eine Planungsschätzung anhand des amerikanischen Zolltarifs (die Revision ist angegeben) und der im Federal Register veröffentlichten Maßnahmen zum angegebenen Datum, für eine Sendung mit Ursprung in der EU. Es ist keine Zollanmeldung, keine Rechtsberatung und keine Einschätzung eines Zollagenten, und zollcodes.de ist kein in den USA zugelassener Zollagent. Der amerikanische Einführer oder sein Zollagent bestätigt vor der Anmeldung die Tarifierung, den Ursprung, den Wert und den fälligen Zoll.

Die hier gezeigten Zollsätze sind Schätzwerte, die amtlichen EU-/deutschen, norwegischen und britischen Zolltarifdaten entnommen wurden, und dienen nur zur Orientierung. Prüfen Sie den aktuellen Zollsatz im EZT-online des deutschen Zolls, in TARIC, beim norwegischen Zoll oder im britischen Online Trade Tariff, bevor Sie Ihre Zollanmeldung abgeben. Der zu zahlende Zollsatz kann außerdem vom Ursprungsland abhängen. Dies sind nur die Grundzollsätze: Einfuhrumsatzsteuer, Verbrauchsteuern, Antidumpingzölle sowie Schutz- und Kontingentmaßnahmen sind nicht enthalten.